electroCore to Participate at Two Upcoming Investor Conferences
03/03/2021 - 04:30 PM
ROCKAWAY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management will participate in two upcoming investor conferences.
H.C. Wainwright Global Life Sciences Conference Format: pre-recorded fireside chat followed by 1x1 virtual investor meetings Date: March 9 – 10 The fireside chat will be available for viewing beginning on Tuesday, March 9, 2021 at 7:00 a.m. ET.
Following the conference a webcast replay of the presentation will be available for 90 days on the Investor section of the company’s website, www.electrocore.com
M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference Format: pre-recorded corporate presentation followed by 1x1 virtual investor meetings Date: March 17 – 18 The presentation will be available for viewing beginning on Wednesday, March 17, 2021 at 9:00 a.m. ET.
Investors can register for the conference HERE .
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.
For more information, visit www.electrocore.com.
Investors:
Hans Vitzthum LifeSci Advisors 617-430-7578hans@lifesciadvisors.com
or
Media Contact:
Summer Diaz electroCore 973-290-0097summer.diaz@electrocore.com
ECOR Rankings
#411 Ranked by Stock Gains
ECOR Stock Data
Industry
Electromedical and Electrotherapeutic Apparatus Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Electromedical and Electrotherapeutic Apparatus Manufacturing
Country
United States
About ECOR
electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.